Skip to main content
. 2020 May 3;75(12):2299–2303. doi: 10.1093/gerona/glaa108

Table 1.

Cohort Characteristics and Summary of Measured Values

Characteristic or Measure n Mean ± SD (Median, Range) or n (%)
Age 117 39.0 ± 12.9 (35, 21–72)
 21–29 33 (28.2)
 30–39 37 (31.6)
 40–49 23 (19.7)
 50–59 11 (9.4)
 > 60 13 (11.1)
Race 117
 Asian 4 (3.4)
 African American/black 6 (5.1)
 Other 4 (3.4)
 White 103 (88.1)
BMI 117 27.0 ± 5.7 (26.5, 18.2–51.6)
 <19.0 1 (0.9)
 19.0–24.9 47 (40.2)
 25.0–29.9 42 (35.9)
 30.0–39.9 24 (20.5)
 40+ 3 (2.6)
Comorbidities 117
 None 102 (87.2)
 One 13 (11.1)
 Two 1 (0.9)
 Three 1 (0.9)
Smoking status 117
 Current smoker 2 (1.7)
 Former smoker 21 (18.0)
 Nonsmoker 94 (80.3)
Pack-years 117 1.2 ± 3.6 (0, 0–23.5)
DNAm 117 27.1 ± 14.1 (22.9, 9.1–65.2)
p16INK4a 114 3.0 ± 1.0 (2.9, 0.4–6.6)
% CD3+ 116 96.0 ± 4.9 (97.0, 60.9–98.7)
CMV seropositivity 117
 Yes 45 (38.5)
 No 72 (61.5)
CMV antibody titer 45 2.8 ± 0.4 (2.9, 2.0–3.5)